Parametric Portfolio Associates’s Applied Therapeutics APLT Stock Holding History

Parametric Portfolio Associates’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$57K	Buy	+26,981	New	+$72.3K	﹤0.01%	3621

Other funds holding APLT

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's APLT Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Applied Therapeutics (APLT) in Q1 2022: 26,981 shares worth $57K. The stake represents ﹤0.01% of the portfolio and ranks #3621 among its holdings.

71 funds tracked by Wall St. Rank hold APLT as of Q1 2022.

Parametric Portfolio Associates held 26,981 shares of Applied Therapeutics worth $57K as of Q1 2022.
Applied Therapeutics was a new Parametric Portfolio Associates position in Q1 2022.
Applied Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3621 holding.
71 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.